Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Manufacturing companies based in London. Multinational companies headquartered in England. Pharmaceutical companies of England. Vaccine producers.
Start downloading a Wikipedia database dump file such as an English Wikipedia dump. It is best to use a download manager such as GetRight so you can resume downloading the file even if your computer crashes or is shut down during the download. Download XAMPPLITE from [2] (you must get the 1.5.0 version for it to work).
MediaWiki, made in PHP. Enciclopedia Libre Universal en Español (English: Universal Free Encyclopedia in Spanish) is a Spanish-language wiki -based online encyclopedia, released under the Creative Commons Attribution-ShareAlike License 3.0. It uses the MediaWiki software. It started as a fork of the Spanish Wikipedia.
Molar mass. 72 971.34 g·mol −1. Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2 diabetes. As of 2017 it is unclear if it affects a person's risk of death. [2] In 2017 GSK announced Albiglutide's withdrawal ...
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.